Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
332.92
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,796
Open
332.92
Bid (Size)
334.00 (1)
Ask (Size)
337.90 (1)
Prev. Close
332.92
Today's Range
332.92 - 332.92
52wk Range
249.70 - 346.85
Shares Outstanding
N/A
Dividend Yield
2.56%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
The Bull Market Strengthened, Let The Naysayers Say Nay...
September 15, 2024
Being able to recite the potential problems in the world does not make you a good investor.
Via
Talk Markets
Performance
YTD
+11.95%
+11.95%
1 Month
+1.51%
+1.51%
3 Month
+7.43%
+7.43%
6 Month
+21.93%
+21.93%
1 Year
+25.96%
+25.96%
More News
Read More
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Via
Talk Markets
Topics
ETFs
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500
September 13, 2024
Via
The Motley Fool
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
September 12, 2024
Via
The Motley Fool
(AMGN) - Analyzing Amgen's Short Interest
September 03, 2024
Via
Benzinga
Amgen Unusual Options Activity For August 29
August 29, 2024
Via
Benzinga
Smart Money Is Betting Big In AMGN Options
August 12, 2024
Via
Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Via
Benzinga
Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival
September 10, 2024
Via
Investor's Business Daily
Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
September 08, 2024
Via
Talk Markets
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
September 05, 2024
Via
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Patchy But Still Bullish
September 02, 2024
Via
Talk Markets
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
Via
Investor's Business Daily
Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'
August 29, 2024
Via
Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
August 27, 2024
Via
Investor's Business Daily
Eli Lilly’s Path to the Next Trillion Market Capitalization
August 26, 2024
Via
MarketBeat
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
Via
The Motley Fool
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
August 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ProInvestor Insights - August 2024
August 19, 2024
Via
Talk Markets
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
August 18, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline
August 17, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
August 15, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.